Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.

Akula SM, Candido S, Libra M, Abrams SL, Steelman LS, Lertpiriyapong K, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-Silva B, Matias de Alencar S, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lin HL, Lombardi P, McCubrey JA.

Adv Biol Regul. 2019 Aug;73:100633. doi: 10.1016/j.jbior.2019.04.003. Epub 2019 Apr 21.

PMID:
31047842
2.

Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals.

Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Bueno-Silva B, de Alencar SM, Lombardi P, Mao W, Montalto G, Cervello M, Rakus D, Gizak A, Lin HL, Libra M, Akula SM, McCubrey JA.

Adv Biol Regul. 2019 May;72:22-40. doi: 10.1016/j.jbior.2019.03.002. Epub 2019 Mar 15.

PMID:
30898612
3.

Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.

Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA.

Adv Biol Regul. 2019 Jan;71:172-182. doi: 10.1016/j.jbior.2018.10.003. Epub 2018 Oct 17.

PMID:
30361003
4.

Synthesis and biological evaluation of novel heteroring-annulated pyrrolino-tetrahydroberberine analogues as antioxidant agents.

Mari G, Catalani S, Antonini E, De Crescentini L, Mantellini F, Santeusanio S, Lombardi P, Amicucci A, Battistelli S, Benedetti S, Palma F.

Bioorg Med Chem. 2018 Oct 1;26(18):5037-5044. doi: 10.1016/j.bmc.2018.08.038. Epub 2018 Sep 1.

PMID:
30196978
5.

Antitumor activity of NAX060: A novel semisynthetic berberine derivative in breast cancer cells.

Pierpaoli E, Fiorillo G, Lombardi P, Salvatore C, Geroni C, Piacenza F, Provinciali M.

Biofactors. 2018 Sep;44(5):443-452. doi: 10.1002/biof.1440. Epub 2018 Sep 3.

PMID:
30178609
6.

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.

Abrams SL, Lertpiriyapong K, Yang LV, Martelli AM, Cocco L, Ratti S, Falasca M, Murata RM, Rosalen PL, Lombardi P, Libra M, Candido S, Montalto G, Cervello M, Steelman LS, McCubrey JA.

Adv Biol Regul. 2018 Aug;69:16-34. doi: 10.1016/j.jbior.2018.06.002. Epub 2018 Jun 28.

PMID:
29980405
7.

Targeting human telomeric DNA quadruplex with novel berberrubine derivatives: insights from spectroscopic and docking studies.

Saha U, Yasmeen Khan A, Bhuiya S, Das S, Fiorillo G, Lombardi P, Suresh Kumar G.

J Biomol Struct Dyn. 2019 Apr;37(6):1375-1389. doi: 10.1080/07391102.2018.1459319. Epub 2018 Apr 23.

PMID:
29607778
8.

Metformin influences drug sensitivity in pancreatic cancer cells.

Candido S, Abrams SL, Steelman L, Lertpiriyapong K, Martelli AM, Cocco L, Ratti S, Follo MY, Murata RM, Rosalen PL, Lombardi P, Montalto G, Cervello M, Gizak A, Rakus D, Suh PG, Libra M, McCubrey JA.

Adv Biol Regul. 2018 May;68:13-30. doi: 10.1016/j.jbior.2018.02.002. Epub 2018 Feb 12.

PMID:
29482945
9.

Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals.

McCubrey JA, Abrams SL, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Lombardi P, Montalto G, Cervello M, Gizak A, Rakus D, Steelman LS.

Adv Biol Regul. 2018 Jan;67:190-211. doi: 10.1016/j.jbior.2017.09.012. Epub 2017 Oct 3.

PMID:
28988970
10.

Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.

McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM, Cocco L, Ratti S, Martelli AM, Laidler P, Dulińska-Litewka J, Rakus D, Gizak A, Lombardi P, Nicoletti F, Candido S, Libra M, Montalto G, Cervello M.

Aging (Albany NY). 2017 Jun 12;9(6):1477-1536. doi: 10.18632/aging.101250. Review.

11.

EMQN best practice guidelines for the molecular genetic testing and reporting of chromosome 11p15 imprinting disorders: Silver-Russell and Beckwith-Wiedemann syndrome.

Eggermann K, Bliek J, Brioude F, Algar E, Buiting K, Russo S, Tümer Z, Monk D, Moore G, Antoniadi T, Macdonald F, Netchine I, Lombardi P, Soellner L, Begemann M, Prawitt D, Maher ER, Mannens M, Riccio A, Weksberg R, Lapunzina P, Grønskov K, Mackay DJ, Eggermann T.

Eur J Hum Genet. 2016 Oct;24(10):1377-87. doi: 10.1038/ejhg.2016.45. Epub 2016 May 11.

12.

Solution and Solid-State Analysis of Binding of 13-Substituted Berberine Analogues to Human Telomeric G-quadruplexes.

Ferraroni M, Bazzicalupi C, Papi F, Fiorillo G, Guamán-Ortiz LM, Nocentini A, Scovassi AI, Lombardi P, Gratteri P.

Chem Asian J. 2016 Apr 5;11(7):1107-15. doi: 10.1002/asia.201600116. Epub 2016 Mar 11.

PMID:
26865223
13.

Effect of new berberine derivatives on colon cancer cells.

Guamán Ortiz LM, Croce AL, Aredia F, Sapienza S, Fiorillo G, Syeda TM, Buzzetti F, Lombardi P, Scovassi AI.

Acta Biochim Biophys Sin (Shanghai). 2015 Oct;47(10):824-33. doi: 10.1093/abbs/gmv077. Epub 2015 Sep 3.

PMID:
26341980
14.

Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.

Pierpaoli E, Damiani E, Orlando F, Lucarini G, Bartozzi B, Lombardi P, Salvatore C, Geroni C, Donati A, Provinciali M.

Carcinogenesis. 2015 Oct;36(10):1169-79. doi: 10.1093/carcin/bgv103. Epub 2015 Jul 13.

PMID:
26168818
15.

Recognition of human telomeric G-quadruplex DNA by berberine analogs: effect of substitution at the 9 and 13 positions of the isoquinoline moiety.

Bhowmik D, Fiorillo G, Lombardi P, Kumar GS.

J Mol Recognit. 2015 Dec;28(12):722-30. doi: 10.1002/jmr.2486. Epub 2015 Jul 3.

PMID:
26138009
16.

Role of 13-(di)phenylalkyl berberine derivatives in the modulation of the activity of human topoisomerase IB.

Vieira S, Castelli S, Falconi M, Takarada J, Fiorillo G, Buzzetti F, Lombardi P, Desideri A.

Int J Biol Macromol. 2015;77:68-75. doi: 10.1016/j.ijbiomac.2015.02.051. Epub 2015 Mar 14.

PMID:
25783020
17.

Berberine, an epiphany against cancer.

Ortiz LM, Lombardi P, Tillhon M, Scovassi AI.

Molecules. 2014 Aug 15;19(8):12349-67. doi: 10.3390/molecules190812349. Review.

18.

Multiple effects of berberine derivatives on colon cancer cells.

Guamán Ortiz LM, Tillhon M, Parks M, Dutto I, Prosperi E, Savio M, Arcamone AG, Buzzetti F, Lombardi P, Scovassi AI.

Biomed Res Int. 2014;2014:924585. doi: 10.1155/2014/924585. Epub 2014 Jun 18.

19.

Spectroscopic studies on the binding interaction of novel 13-phenylalkyl analogs of the natural alkaloid berberine to nucleic acid triplexes.

Bhowmik D, Buzzetti F, Fiorillo G, Lombardi P, Suresh Kumar G.

Spectrochim Acta A Mol Biomol Spectrosc. 2014;120:257-64. doi: 10.1016/j.saa.2013.09.081. Epub 2013 Oct 7.

PMID:
24184628
20.

Antitumor effect of novel berberine derivatives in breast cancer cells.

Pierpaoli E, Arcamone AG, Buzzetti F, Lombardi P, Salvatore C, Provinciali M.

Biofactors. 2013 Nov-Dec;39(6):672-9. doi: 10.1002/biof.1131. Epub 2013 Sep 2.

PMID:
24000115

Supplemental Content

Loading ...
Support Center